Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycobacterium gordonae: a new pathogen?

J G Douglas, M A Calder, Y F Choo-Kang

    Thorax
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomised trial of home energy efficiency improvement in the homes of elderly COPD patients.

    The European respiratory journal·2009
    Same author

    Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial.

    Scottish medical journal·2009
    Same author

    The changing face of infection: a comparative review of admissions to a regional infection unit over three decades.

    Scottish medical journal·2007
    Same author

    Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor.

    Kidney international·2006
    Same author

    Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.

    Thorax·2004
    Same author

    Relationship between birth weight and adult lung function: controlling for maternal factors.

    Thorax·2003
    Same journal

    Mediastinal amyloidosis mimicking advanced lung cancer.

    Thorax·2026
    Same journal

    Comparative performance of endobronchial ultrasound-guided sampling techniques in patients with mediastinal lesions: a network meta-analysis.

    Thorax·2026
    Same journal

    Vitamin A and D impact on lung function: differential or common effects across the lifespan?

    Thorax·2026
    Same journal

    The impact of vitamins A and D on lung function and regulatory epigenetics in adult and childhood asthma.

    Thorax·2026
    Same journal

    Radiological factors associated with the recurrence of <i>Mycobacterium avium complex</i> pulmonary disease: a multicentre retrospective cohort study.

    Thorax·2026
    Same journal

    Daughter vesicles in primary diaphragmatic hydatid cyst.

    Thorax·2026
    See all related articles

    Mycobacterium gordonae, typically a non-pathogenic water contaminant, may cause pulmonary disease. This report details two such cases and reviews recent experiences with this organism.

    Area of Science:

    • Microbiology
    • Infectious Diseases

    Background:

    • Mycobacterium gordonae is a slow-growing, scotochromogenic, acid-fast bacillus (Runyon group II).
    • It is commonly found as a contaminant in water, soil, and raw milk.
    • Generally considered saprophytic and non-pathogenic in humans.

    Observation:

    • Two recent cases of pulmonary disease potentially caused by Mycobacterium gordonae were observed.
    • These cases suggest a possible pathogenic role for this organism in humans.

    Findings:

    • The study reports on two clinical cases of pulmonary disease linked to Mycobacterium gordonae.
    • It reviews the institution's recent experience with isolating this bacterium.

    Implications:

    • This research highlights the potential for Mycobacterium gordonae to cause human disease, challenging its traditional non-pathogenic classification.

    Related Experiment Videos

  • Further investigation into the pathogenicity of Mycobacterium gordonae is warranted.